Literature DB >> 18190972

Role of muscarinic receptors in the regulation of immune and inflammatory responses.

Seddigheh Razani-Boroujerdi1, Muskaan Behl, Fletcher F Hahn, Juan Carlos Pena-Philippides, Julie Hutt, Mohan L Sopori.   

Abstract

Leukocytes contain both nicotinic and muscarinic receptors, and while activation of nicotinic receptors suppresses immune/inflammatory responses, the role of muscarinic receptors in immunity is unclear. We examined the effects of a muscarinic receptor antagonist (atropine) and agonist (oxotremorine), administered chronically through miniosmotic pumps, on immune/inflammatory responses in the rat. Results show that while oxotremorine stimulated, atropine inhibited the antibody and T-cell proliferative responses. Moreover, atropine also suppressed the turpentine-induced leukocytic infiltration and tissue injury, and inhibited chemotaxis of leukocytes toward neutrophil and monocyte/lymphocyte chemoattractants. Thus, activation of nicotinic and muscarinic receptors has opposite effects on the immune/inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190972      PMCID: PMC2323336          DOI: 10.1016/j.jneuroim.2007.11.019

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  27 in total

1.  The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system.

Authors:  Jun Nomura; Toru Hosoi; Yasunobu Okuma; Yasuyuki Nomura
Journal:  Life Sci       Date:  2003-03-28       Impact factor: 5.037

Review 2.  Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway.

Authors:  Christopher J Czura; Steven G Friedman; Kevin J Tracey
Journal:  J Endotoxin Res       Date:  2003

Review 3.  The syntax of immune-neuroendocrine communication.

Authors:  J E Blalock
Journal:  Immunol Today       Date:  1994-11

4.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

Authors:  L X Fu; Y Magnusson; C H Bergh; J A Liljeqvist; F Waagstein; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

5.  Effect of vagotomy on anaphylaxis in the rat.

Authors:  R M Levy; J E Rose; J S Johnson
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

Review 6.  Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function.

Authors:  Koichiro Kawashima; Takeshi Fujii
Journal:  Front Biosci       Date:  2004-09-01

7.  Muscarinic cholinergic receptors on intact human lymphocytes. Properties and subclass characterization.

Authors:  B Bering; H W Moises; W E Müller
Journal:  Biol Psychiatry       Date:  1987-12       Impact factor: 13.382

8.  Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis.

Authors:  B Anlar; J W Karaszewski; A T Reder; B G Arnason
Journal:  J Neuroimmunol       Date:  1992-02       Impact factor: 3.478

9.  T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response.

Authors:  Seddigheh Razani-Boroujerdi; R Thomas Boyd; Martha I Dávila-García; Jayashree S Nandi; Neerad C Mishra; Shashi P Singh; Juan Carlos Pena-Philippides; Raymond Langley; Mohan L Sopori
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

10.  The history of drugs for the treatment of Parkinson's disease.

Authors:  W Kapp
Journal:  J Neural Transm Suppl       Date:  1992
View more
  28 in total

Review 1.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

Review 2.  Possible role for anisodamine in organophosphate poisoning.

Authors:  Arik Eisenkraft; Avshalom Falk
Journal:  Br J Pharmacol       Date:  2016-04-22       Impact factor: 8.739

Review 3.  Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier.

Authors:  Damir Janigro
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

4.  Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium.

Authors:  Leon P McLean; Allen Smith; Lumei Cheung; Rex Sun; Viktoriya Grinchuk; Tim Vanuytsel; Neemesh Desai; Joseph F Urban; Aiping Zhao; Jean-Pierre Raufman; Terez Shea-Donohue
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

5.  Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness.

Authors:  Siomara Hernandez; David E Fried; Vladimir Grubišić; Jonathon L McClain; Brian D Gulbransen
Journal:  FASEB J       Date:  2019-02-21       Impact factor: 5.191

Review 6.  Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases.

Authors:  Khuder Alagha; Alain Palot; Tunde Sofalvi; Laurie Pahus; Marion Gouitaa; Celine Tummino; Stephanie Martinez; Denis Charpin; Arnaud Bourdin; Pascal Chanez
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

7.  Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.

Authors:  Yihe Chen; Sunil K Chauhan; Hyun Soo Lee; William Stevenson; Chris S Schaumburg; Zahra Sadrai; Daniel R Saban; Shilpa Kodati; Michael E Stern; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-03       Impact factor: 4.799

8.  Nitric oxide synthase 1 and cyclooxygenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells.

Authors:  A J Español; N Goren; M L Ribeiro; María Elena Sales
Journal:  Inflamm Res       Date:  2009-10-13       Impact factor: 4.575

9.  Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population.

Authors:  David T Gamble; Allan B Clark; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw; Phyo K Myint
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

Review 10.  Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease?

Authors:  Noha Zoheir; David F Lappin; Christopher J Nile
Journal:  Inflamm Res       Date:  2012-07-10       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.